Skip to content

OPTIMIzing patient selection for deep brain STimulation of the subthalamic nucleus in Parkinson’s disease: the OPTIMIST study

OPTIMIzing patient selection for deep brain STimulation of the subthalamic nucleus in Parkinson’s disease: the OPTIMIST study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON21813
Enrollment
83
Registered
2017-01-24
Start date
2017-01-31
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease, Deep Brain Stimulation, Parkinson's disease dementia (PDD)

Interventions

No intervention is formally tested. Patients eligible for STN-DBS after routine screening in the DBS centres will be operated on according to standard procedures. Questionnaires and rating scales will

Sponsors

Leiden University Medical Center, dept. of Neurology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age > 18 years Diagnosis of idiopathic Parkinson's disease Clinical indication for STN-DBS at the participating centres Ability to give informed consent Ability to comply with the study assessments Ability to read or understand Dutch

Exclusion criteria

Exclusion criteria: Exclusion criteria (contra-indications) for STN-DBS: Parkinson's disease severity: HY stage 5 Score on Mattis Dementia Rating scale <120 Psychiatric contraindications for STN-DBS General contra-indications for stereotactic surgery and/or general anaesthesia

Design outcomes

Primary

MeasureTime frame
Success to STN DBS is quantified as the difference in MDS-UPDRS motor scores measured during an acute stimulation challenge

Secondary

MeasureTime frame
Psychotic symptoms in the 72 hours following surgery, measured by DOS Global satisfaction with surgery scale SENS-PD composite score MDS-UPDRS motor score Cognitive decline 12 months after surgery

Contacts

Public ContactM.F. Contarino

Leiden University Medical Center, Dept. of Neurology K5Q-103

Email: m.f.contarino@lumc.nlTel: 0031(0)7171 526 3964

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)